Patient Access AI Security Review for Healthcare

Patient Access AI Security Review for Healthcare

A patient-access AI security review should follow one configured journey, from a patient's request to the record a staff member can correct. For scheduling and intake, a polished interface can conceal wrong-patient matches, overbroad service credentials, messages sent to the wrong contact, partial writes, and a queue that cannot be recovered after an outage. Ask for evidence from the proposed configuration before treating a vendor's control description as a result.

This guide is for healthcare technology research and procurement planning. It is not medical, legal, privacy, billing, coding, reimbursement, or compliance advice. Qualified local owners must determine the applicable obligations and evaluate the actual organization, product, version, data, and workflow. The questions below describe a buyer-owned review packet, not a security certification or a claim that any product was tested.

Follow one hypothetical appointment request

Use this hypothetical field example to keep the review concrete. Imagine a patient starts a self-scheduling request, a system checks identity, an assistant proposes an available slot, a scheduling system records the appointment, and a message service sends confirmation. A failed step moves the request to a staff exception queue. This is not an observed deployment: every field, control, test result, contract term, and decision remains unknown — local owner/evidence required until the buyer obtains its own records.

• Appointment request: [request ID, patient or proxy channel, requested service, location, time window, minimum required contact details, source system, included population — open]. Avoid putting an entire intake narrative or unnecessary clinical detail into a scheduling prompt.
• Identity and proxy check: [match source, verification method, proxy authority, duplicate or merged-record handling, uncertain-match route, reviewer — open]. A matching score alone does not identify who may act for the patient.
• Scheduling write: [proposed slot, authoritative schedule, write permission, transaction ID, duplicate and retry behavior, cancellation or correction path — open]. A successful API response is not proof that the intended patient and appointment record were reconciled.
• Confirmation and reminder: [approved recipient, contact preference, channel, message template or generated text, suppression rule, delivery status, incorrect-recipient procedure — open]. A reminder may disclose information even when the appointment itself was correct.
• Exception queue: [reason, owner, due action, safe manual channel, paused automation state, affected-record list, audit link — open]. A request is not safely handled merely because it disappeared from the automated path.

Draw the trust boundary between the patient or proxy, the buyer's identity and scheduling systems, the AI service, a model or messaging subprocessor, staff, and any backup or analytics system. Mark which system is authoritative for each field, who can change it, and which actions are read-only, recommended, or written back. If the product also checks eligibility, routes referrals, handles record-access requests, connects a patient-designated independent app, or classifies clinical urgency, add a separate function and applicability branch. Evidence from this administrative example cannot be carried over automatically.

Six security-control gates

Run these gates for the exact module, build, location, population, language, channel, integration, and staff role proposed. Each gate should point to a dated artifact, a local reviewer, and a way to record uncertainty. The gates organize due diligence; they do not themselves approve a product.

Gate 1: bound the function, data, and actors

Identify where the request begins, which fields cross each boundary, what the AI sees or creates, where logs and backups go, and which party controls every transfer. Separate appointment metadata from referral content, insurance details, call transcripts, and any clinical message. Determine the covered-entity, business-associate, subcontractor, or independent-app relationship from facts rather than a product label. Mark which flows are out of scope.

Evidence to request: a versioned field-level flow, system and processor inventory, input/output and write-authority map, purpose and retention schedule, and contract or role analysis for the proposed deployment. Include support access, telemetry, message gateways, model APIs, and backups if they receive data.

Owner to name: patient-access workflow owner, EHR/scheduling data owner, privacy/legal reviewer for roles and PHI, and security architect for the technical boundary.

Pause or escalate when: no one can name the authoritative record, a processor or secondary use is undisclosed, the proposed data exceeds the stated purpose, or a record-access, payer API, or clinical function is being folded into a scheduling approval without its own review.

Gate 2: verify identity, authority, and recipients

Walk through patient, proxy, scheduler, registrar, administrator, vendor support, and service-account privileges. Test the decision points for duplicate records, changed contact details, shared phones, stale proxy authority, and staff override. A message or write must not be triggered from an uncertain identity simply because the interface offers a slot.

Evidence to request: identity and proxy policy, configured authentication and authorization export, role matrix, privileged-access logs, contact-preference and recipient rules, and scenario results for wrong-patient, duplicate, merge, lost-device, and revoked-proxy cases. Ask how an error is detected before a disclosure and how the affected person is found afterward.

Owner to name: registration or health-information management, patient-access operations, identity/IT, privacy, and the person authorized to freeze messages or writes.

Pause or escalate when: proxy authority is unresolved, a shared account can approve or send without attribution, a wrong-recipient route lacks a stop, or vendor support can access records beyond the reviewed role and purpose.

Gate 3: reconstruct transactions and corrections

For create, reschedule, cancel, eligibility, referral, and message transactions actually in scope, identify the request, response, system of record, version, actor, retry, duplicate prevention, and downstream effect. Ask the team to reconstruct one changed request without relying on a vendor dashboard. An audit log should let the buyer trace a correction without erasing the original action.

Evidence to request: interface specification, event and transaction IDs, field mapping, audit coverage and retention, configured logs, and buyer-observed tests of partial failure, stale availability, duplicate retry, incorrect record, correction, and reconciliation. Keep expected and observed outcomes in separate columns; a design document is not an observed result.

Owner to name: scheduling/EHR integration owner, data steward, security logging owner, and staff member responsible for correcting affected records.

Pause or escalate when: the team cannot identify affected patients or messages, cannot detect an unauthorized write or partial success, cannot restore the authoritative state, or has no audit trail for the correction.

Gate 4: inspect suppliers, use, retention, and change

List hosting, model, messaging, analytics, support, and backup suppliers that can receive request data. Compare the permitted-use and deletion terms with the actual configuration. A BAA, where required, is one part of that comparison; it does not show that prompt, log, retention, or subprocessor behavior matches the agreement. Model training or product-improvement use needs its own factual and contractual review.

Evidence to request: current supplier and subprocessor list, relevant agreement versions, data-use settings, support-access record, storage/backup regions, retention and deletion procedure, sample export, change notice, and evidence of an authorized deletion or access-revocation test in the proposed service. Record which promises are vendor assertions and which have local evidence.

Owner to name: vendor management, privacy/legal for permitted use and agreements, security for configuration, and records/data governance for retention and exit.

Pause or escalate when: a new processor or model receives unreviewed data, a required agreement is unresolved, a prohibited reuse cannot be disabled, the buyer cannot export or verify deletion, or a material change has no notice and renewed-review path.

Gate 5: contain incidents and recover queues

Plan for a wrong-patient match, wrong-recipient message, compromised service credential, failed write, lost referral, or vendor/interface outage. Separate stopping new AI actions from stopping the underlying scheduling service; staff may still need a manual path. Preserve evidence, find every affected request, protect queued work, and reconcile before resuming automation.

Evidence to request: incident roles and contractual notice route, detection and log-preservation plan, pause controls, manual queue procedure, backup/restore and replay design, duplicate prevention, affected-record enumeration, and an authorized exercise plan with blank observed-result and retest fields. A published uptime target is not a local recovery exercise.

Owner to name: incident commander, patient-access operations, integration/data owner, privacy for breach triage where applicable, and vendor support contact.

Pause or escalate when: no one can disable outbound messages or writes, the queue can be lost or replayed twice, affected patients cannot be enumerated, or recovery depends on an undocumented vendor action. Do not mark an exercise passed before it occurs.

Gate 6: decide, expire, and reopen

Connect each control to its scope, artifact, observation, owner, limitation, open finding, corrective action, and next review. Keep administrative scheduling apart from any clinical triage or record-access function. A change in channel, patient group, model, routing rule, data source, vendor, privilege, or message content can invalidate earlier evidence.

Evidence to request: control-to-evidence matrix, versioned decision record, unresolved exception register, condition and expiry fields, change triggers, and a reviewer plan for retesting. Record a vendor assertion, buyer-observed result, and authority record separately; a blank result is not a pass.

Owner to name: accountable patient-access leader, security decision owner, privacy/legal or clinical owner for triggered branches, and operator with pause authority.

Pause or escalate when: an identity, disclosure, integrity, audit, or recovery control lacks an owner or verifiable evidence; a conditional decision has no limit or expiry; or expansion is proposed on the strength of price, projected ROI, or a prior deployment's approval.

Assemble six buyer-owned artifacts

Keep these records exportable outside a vendor portal. Start each result field blank or marked unknown — local owner/evidence required. In every artifact distinguish the vendor assertion, the buyer-observed result, and the authority record that states who decided what, for which version and scope. Unknown is not zero: no reported incident is not an observed zero-incident period, and an unrun recovery exercise is not a pass. Use pass, fail, conditional, or open only after recording the supporting evidence and decision owner.

A. Workflow and trust-boundary map

Record the patient or proxy trigger; included and excluded functions, people, locations and channels; each data element's source and destination; AI/model, scheduling/EHR, messaging, support, analytics and backup boundaries; read/write authority; and where manual review enters. Leave actual systems, processors and PHI classification blank until the buyer verifies them.

B. Identity, access, and recipient matrix

List patient, proxy, staff, administrator, vendor and service-account roles against read, create, change, cancel, send, export, audit and pause powers. Add authentication, proxy proof, contact preferences, privileged access, expiry and revocation evidence. Keep the wrong-patient and wrong-recipient test results open until run.

C. Transaction, audit, and reconciliation record

For each configured action, link expected behavior, transaction and event IDs, authoritative record, retry/idempotency rule, observed result, affected-record enumeration, correction, downstream reconciliation, tester, date and retest. Do not turn an HTTP success or a dashboard count into record-level proof.

D. Supplier, use, retention, and deletion matrix

Name every supplier, subprocessor, data category, purpose, location, model-use setting, permitted/secondary use, support access, retention, backup, export and deletion path. Link contract terms and applicable BAA obligations to configuration and observed evidence rather than treating a signed document as a control test.

E. Incident, pause, and recovery exercise request

Specify the scenario, expected detection, stop control, evidence preservation, notification owner, safe manual queue, restoration order, replay protection, affected-record reconciliation, observed-result blank, defect, correction and retest. The buyer must authorize and observe any exercise before reporting an outcome.

F. Control, exception, and expiry record

Index each gate's evidence, limitation, owner, status, condition, remediation, due date, decision authority, approved scope, expiry and renewed-review trigger. Preserve negative findings and abandoned approaches so a future reviewer can reconstruct why the boundary was limited.

Apply official sources conditionally

The NIST AI Risk Management Framework 1.0 and NIST Cybersecurity Framework 2.0 are voluntary ways to organize AI and security risks and outcomes. Neither is a product certification or evidence that this configured patient-access workflow passed a control. Use the NIST Generative AI Profile only if the actual workflow uses generative AI, prompts, retrieval or model-driven tool calls; do not assign prompt-injection claims to a rules-only engine.

First establish the organization, data and relationship. The HHS covered-entity and business-associate guidance frames whether a supplier acts on behalf of a regulated entity. For a covered entity or business associate handling ePHI, the HHS summary of the Security Rule currently in effect supports questions about risk analysis, access, audit, authentication, transmission, incident procedures and recovery. The 2024 Security Rule NPRM remains proposed; do not write its suggested changes as current obligations. The HHS cloud guidance can inform cloud responsibility and BAA questions, but a contract or encryption claim does not prove the local configuration.

Do not force one BAA answer onto every patient-facing app. The HHS FAQ on a patient-designated independent app explains that a BAA is not required with an app developer that is not acting on behalf of or for the covered entity to receive the individual's requested ePHI. That is a different fact pattern from a provider-contracted scheduling vendor. The qualified owner must still evaluate the actual app role, data flow, security and other applicable obligations.

If a distinct feature recommends clinical care or classifies urgency, use the FDA Clinical Decision Support Software guidance to frame function-specific intended-use questions; administrative scheduling alone does not trigger that conclusion. The ASTP/ONC Decision Support Interventions test method is relevant only to the specified Predictive DSI supplied as part of a certified Health IT Module. Neither source determines the status, safety or security of an unidentified patient-access product. If the function includes a payer API, record-access request, or information-sharing practice, send its actor, rule, version and evidence to the corresponding qualified owner before citing a universal requirement.

Hand off adjacent decisions

Use this page to produce one configured workflow's security evidence packet. Send other decisions to the page that owns them:

• The patient-access tool shortlist owns the multi-lane eight-gate screening and whether a candidate advances; this packet deepens its security gate after a function is bounded.
• The patient-access vendor evaluation guide compares finalists using common scenarios and acceptance evidence; this page does not rank suppliers.
• The patient-access buyer checklist owns broad procurement questions, while the patient-access compliance questions route legal, privacy and contract applicability to qualified owners.
• The patient-access pilot planning guide sets cohorts, baselines and expansion gates; the patient-access workflow implementation guide owns staffing, training and the operating runbook. Security test requests and findings become inputs to those plans.
• What to check before using AI with PHI and vendor security and BAA review cover cross-product data and supplier diligence. This page focuses on patient/proxy identity, appointment and referral records, communication recipients, write-back integrity and queue recovery.

If the buyer cannot name the workflow, authoritative record, identity and recipient decisions, write path, or pause owner, stop this security review and define those boundaries first. If the requested packet only repeats a generic security questionnaire, return to the broader shortlist or vendor evaluation process rather than describing an unsupported local security result.

Evidence boundary

These public NIST, HHS, FDA and ASTP/ONC sources frame questions within their stated scope. This guide reports no product test, customer interview, local configuration inspection, PHI exposure, wrong-patient event, incident, recovery exercise, clinical result, security certification, signed BAA, legal conclusion or approval. The hypothetical fields and six artifacts are requests, not completed evidence. Recheck source status, actor, data and app role, function, supplier/model, system version and local records before any operational decision.